Stockscreener 앱 받기
24.84
0.72%
-0.18
시간 외 거래:
24.84
Ideaya Biosciences Inc 주식(IDYA)의 최신 뉴스
Will IDEAYA Biosciences Inc. bounce back from current supportRisk-Managed Swing Setup and Signal Analysis - Newser
Applying Wyckoff theory to IDEAYA Biosciences Inc. stockSwing Setup With Technical Confirmation Explained - metal.it
Chart based analysis of IDEAYA Biosciences Inc. trendsAsset Allocation Summary With Future Outlook - Newser
Will IDEAYA Biosciences Inc. outperform the marketNext Day Momentum Stock Forecasting Report - Newser
Why IDEAYA Biosciences Inc. stock attracts strong analyst attentionFree Proven Entry Plan With Low Risk Trade - Newser
Will IDEAYA Biosciences Inc. stock benefit from AI tech trendsWatchlist Generator With Real-Time Entry - Newser
JPMorgan Chase & Co. Issues Positive Forecast for IDEAYA Biosciences (NASDAQ:IDYA) Stock Price - Defense World
How volatile is IDEAYA Biosciences Inc. stock compared to the marketRetirement Planning Updates For Consistent Profits - jammulinksnews.com
Historical volatility pattern of IDEAYA Biosciences Inc. visualizedProven Trading System with Consistent Gains - Newser
Can IDEAYA Biosciences Inc. rally from current levelsSwing Entry Insight With Forecast Accuracy - Newser
Analyzing net buyer seller activity in IDEAYA Biosciences Inc.Trade Flow Monitor with Volume Tracker - Newser
Evaluating IDEAYA Biosciences Inc. with trendline analysisDaily Pick Forecast with Entry Zones - Newser
What catalysts could drive IDEAYA Biosciences Inc. stock higher in 2025Unlock daily market insights for better decisions - jammulinksnews.com
What is the risk reward ratio of investing in IDEAYA Biosciences Inc. stockHigh-margin investment plays - jammulinksnews.com
IDEAYA Biosciences Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Investing Community - Newser
Should I hold or sell IDEAYA Biosciences Inc. stock in 2025Invest smarter with data-backed trading alerts - jammulinksnews.com
What drives IDEAYA Biosciences Inc. stock priceSignificant capital appreciation - PrintWeekIndia
TD Cowen Bullish on Ideaya’s (IDYA) Oncology Pipeline - MSN
IDEAYA Biosciences (NASDAQ:IDYA) Research Coverage Started at TD Cowen - Defense World
What analysts say about IDEAYA Biosciences Inc. stockTriple-digit profit margins - PrintWeekIndia
Is IDEAYA Biosciences Inc. a good long term investmentRecord-setting profit potential - PrintWeekIndia
What makes IDEAYA Biosciences Inc. stock price move sharplyFree Investing Community - Newser
IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal Melanoma - The Malaysian Reserve
IDEAYA to present phase 2 data on uveal melanoma drug at ESMO - Investing.com Nigeria
IDEAYA to present phase 2 data on uveal melanoma drug at ESMO By Investing.com - Investing.com South Africa
IDEAYA Biosciences Announces 10-Year Anniversary R&D Day on September 8, 2025 to Present Multiple Clinical Data Updates and Outline Future Growth Strategy - Nasdaq
IDEAYA Biosciences: Precision Oncology Pipeline and Synthetic Lethality Catalysts - AInvest
IDEAYA's First-in-Class Cancer Pipeline: Major Clinical Updates Coming at 10th Anniversary R&D Day - Stock Titan
Signaturefd LLC Increases Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World
IDEAYA Biosciences and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849), a Potential First-in-Class DLL3-TOP1 ADC - The Malaysian Reserve
IDEAYA Biosciences Inc. Stock Analysis and ForecastHigh-margin investment plays - jammulinksnews.com
Ideaya Biosciences, Hengrui announce oral presentation at IASLC 2025 - TipRanks
Melanoma Market Anticipates a Dynamic Shift During the Forecast Period (2025–2034) Owing to the Strong Pipeline Activity | DelveInsight - GlobeNewswire Inc.
symbol__ Stock Quote Price and Forecast - CNN
IDEAYA Biosciences: TD Cowen initiates coverage with Buy rating. - AInvest
Promising Pipeline and Strategic Focus Drive Buy Rating for IDEAYA Biosciences - TipRanks
TD Cowen initiates Ideaya Biosciences stock with Buy rating By Investing.com - Investing.com Canada
TD Cowen Initiates Coverage of IDEAYA Biosciences (IDYA) with Buy Recommendation - MSN
10.28%
2.59%
자본화:
|
볼륨(24시간):